forecast
Eli Lilly Using Obesity Drugs to Build Scale
Eli Lilly's GLP-1 franchise in obesity and possibly Alzheimer's, along with LillyDirect, gives it a long, protected revenue tail and a chance to use its winnings to build more control and power over the healthcare value chain.
forecastpending
Speaker
Anne-Marie PetersonEvidence Quote
“If I were running Lilly, I would definitely be figuring out how to invest my winnings into having more control and power.”
Source
Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]— Invest Like the BestCreated: 11/14/2026, 4:41:01 AM
Your notes
Loading notes...